Bibliographic Info
GuidelineWHO recommendations for the prevention and treatment of postpartum haemorrhage
Year of Publication2012
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Low
If intravenous oxytocin is unavailable, or if the bleeding does not respond to oxytocin, the use of intravenous ergometrine, oxytocin-ergometrine fixed dose, or a prostaglandin drug (including sublingual misoprostol, 800 µg) is recommended (for the treatment of postpartum haemorrhage)
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO recommendations on maternal health: guidelines approved by the WHO Guidelines Review Committee, second edition. Geneva: World Health Organization; 2025
Year2023
InstitutionWorld Health Organization